Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Soluble BCMA defines spatial phenotypes and prognosis in newly diagnosed myeloma, with elevated sBCMA rather than tumor volume (imaging-defined) a primary determinant of early treatment failure.”
Title: Soluble BCMA Defines Spatial Phenotypes and Prognosis in Newly Diagnosed Multiple Myeloma
Authors: Masanori Toho, Rikako Tabata, Daisuke Ikeda, Atsushi Uehara, Hajime Sakuma, Kosuke Shima, Daichi Terunuma, Kazuki Nagao, Naoya Fukuda, Fuminari Fujii, Kentaro Narita, Masami Takeuchi, Hiroyuki Takamatsu, Kosei Matsue
You can read the full article on Blood.

You can find other articles featuring Robert Orlowski on OncoDaily.